402 related articles for article (PubMed ID: 20214492)
21. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity.
Kim HJ; Lee JH; Kim SJ; Oh GS; Moon HD; Kwon KB; Park C; Park BH; Lee HK; Chung SY; Park R; So HS
J Neurosci; 2010 Mar; 30(11):3933-46. PubMed ID: 20237264
[TBL] [Abstract][Full Text] [Related]
22. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
23. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
24. Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats.
Lee CH; Park SS; Lee DH; Lee SM; Kim MY; Choi BY; Kim SY
Neurosci Lett; 2020 Mar; 722():134838. PubMed ID: 32061715
[TBL] [Abstract][Full Text] [Related]
25. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
26. Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis.
Wu X; Li X; Song Y; Li H; Bai X; Liu W; Han Y; Xu L; Li J; Zhang D; Wang H; Fan Z
Neuropharmacology; 2017 Apr; 116():429-440. PubMed ID: 28062185
[TBL] [Abstract][Full Text] [Related]
27. [Ototoxicity of kanamycin sulfate in adult rats and its underlying mechanisms].
Zhang ZC; Yu HM; Liu Q; Tian J; Wang TF; Lai CJ; Zhou XY
Sheng Li Xue Bao; 2011 Apr; 63(2):171-6. PubMed ID: 21505733
[TBL] [Abstract][Full Text] [Related]
28. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of cisplatin ototoxicity: theoretical review.
Gonçalves MS; Silveira AF; Teixeira AR; Hyppolito MA
J Laryngol Otol; 2013 Jun; 127(6):536-41. PubMed ID: 23651576
[TBL] [Abstract][Full Text] [Related]
30. Damage and threshold shift resulting from cochlear exposure to paraquat-generated superoxide.
Bielefeld EC; Hu BH; Harris KC; Henderson D
Hear Res; 2005 Sep; 207(1-2):35-42. PubMed ID: 15935579
[TBL] [Abstract][Full Text] [Related]
31. Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs.
Wolters FL; Klis SF; de Groot JC; Hamers FP; Prieskorn DM; Miller JM; Smoorenburg GF
Hear Res; 2003 May; 179(1-2):53-61. PubMed ID: 12742238
[TBL] [Abstract][Full Text] [Related]
32. Wnt Signaling Activates TP53-Induced Glycolysis and Apoptosis Regulator and Protects Against Cisplatin-Induced Spiral Ganglion Neuron Damage in the Mouse Cochlea.
Liu W; Xu X; Fan Z; Sun G; Han Y; Zhang D; Xu L; Wang M; Wang X; Zhang S; Tang M; Li J; Chai R; Wang H
Antioxid Redox Signal; 2019 Apr; 30(11):1389-1410. PubMed ID: 29587485
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of cisplatin-induced ototoxicity and prevention.
Rybak LP; Whitworth CA; Mukherjea D; Ramkumar V
Hear Res; 2007 Apr; 226(1-2):157-67. PubMed ID: 17113254
[TBL] [Abstract][Full Text] [Related]
34. Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster.
Kaltenbach JA; Church MW; Blakley BW; McCaslin DL; Burgio DL
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):493-500. PubMed ID: 9374173
[TBL] [Abstract][Full Text] [Related]
35. Role of the copper transporter, CTR1, in platinum-induced ototoxicity.
More SS; Akil O; Ianculescu AG; Geier EG; Lustig LR; Giacomini KM
J Neurosci; 2010 Jul; 30(28):9500-9. PubMed ID: 20631178
[TBL] [Abstract][Full Text] [Related]
36. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
37. Development and
Nacher-Soler G; Marteyn A; Barenzung N; Sgroi S; Krause KH; Senn P; Rousset F
Front Neurol; 2022; 13():993017. PubMed ID: 36188374
[TBL] [Abstract][Full Text] [Related]
38. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.
Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D
Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408
[TBL] [Abstract][Full Text] [Related]
39. Conservation of endocochlear potential in mice with profound hearing loss induced by co-administration of kanamycin and furosemide.
Xiong H; Chu H; Zhou X; Huang X; Cui Y; Zhou L; Chen J; Li J; Wang Y; Chen Q; Li Z
Lab Anim; 2011 Apr; 45(2):95-102. PubMed ID: 21216844
[TBL] [Abstract][Full Text] [Related]
40. The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss.
Ghosh S; Sheth S; Sheehan K; Mukherjea D; Dhukhwa A; Borse V; Rybak LP; Ramkumar V
Front Cell Neurosci; 2018; 12():271. PubMed ID: 30186120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
